Currently, 80 percent of the world’s adults aged 65 or over have at least one chronic illness, while 68 percent have two or more. The human suffering is huge, and in the next 30 years, the number of over-65-year-olds is projected to double to 1.5 billion. This will be costly.
“If we had a drug that adds even one or two healthy years onto the lifespan, it would have trillions of dollars of effect on the world economy, because people would be productive for longer and they wouldn’t have all these morbidities that cost our healthcare systems so much,” says , chairman of the longevity and healthy aging company Juvenescence.
Read the full article in the latest issue of BBC Science Focus Magazine.